FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/086045 [Registered on: 30/04/2025] Trial Registered Prospectively
Last Modified On: 29/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Other 
Public Title of Study   Incidence of Ventilator-Associated Pneumonia, it’s Clinico-Microbiological profile & Antibiotic Sensitivity Patterns in Mechanically Ventilated ICU Patients 
Scientific Title of Study   Incidence of Ventilator-Associated Pneumonia, it’s Clinico-Microbiological profile & Antibiotic Sensitivity Patterns in mechanically ventilated ICU patients - A prospective observational study. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Puneet Goyal 
Designation  Professor 
Affiliation  Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow 
Address  Department of Anaesthesiology Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow Uttar Pradesh 226014 India

Lucknow
UTTAR PRADESH
226014
India 
Phone  8004904597  
Fax    
Email  princeofcoma@yahoo.co.uk  
 
Details of Contact Person
Scientific Query
 
Name  Puneet Goyal 
Designation  Professor 
Affiliation  Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow 
Address  Department of Anaesthesiology Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow Uttar Pradesh 226014 India


UTTAR PRADESH
226014
India 
Phone  8004904597  
Fax    
Email  princeofcoma@yahoo.co.uk  
 
Details of Contact Person
Public Query
 
Name  Puneet Goyal 
Designation  Professor 
Affiliation  Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow 
Address  Department of Anaesthesiology Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow Uttar Pradesh 226014 India


UTTAR PRADESH
226014
India 
Phone  8004904597  
Fax    
Email  princeofcoma@yahoo.co.uk  
 
Source of Monetary or Material Support  
Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow Uttar Pradesh 226014 India 
 
Primary Sponsor  
Name  Sanjay Gandhi Postgraduate Institute of Medical Sciences  
Address  Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow Uttar Pradesh 226014 India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Esha Kujur  Sanjay Gandhi Postgraduate Institute of Medical Sciences  Department of Anaesthesiology Main Post op ICU PMSSY Post op ICU ATC ICU SGPGI Campus Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow Uttar Pradesh 226014 India
Lucknow
UTTAR PRADESH 
8884963766

esha.v.kujur@gmail.com 
Dr Puneet Goyal  Sanjay Gandhi Postgraduate Institute of Medical Sciences  Department of Anaesthesiology Sanjay Gandhi Postgraduate Institute of Medical Sciences SGPGI Campus Lucknow Uttar Pradesh 226014 India
Lucknow
UTTAR PRADESH 
8004904597

princeofcoma@yahoo.co.uk 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Comittee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J17||Pneumonia in diseases classified elsewhere,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  Adult patients of both gender staying in ICU for more than 48 hours after endotracheal intubation.  
 
ExclusionCriteria 
Details  Negative consent.
Patients admitted to ICU with ETT in situ prior admission.
Patients who are immunocompromised and or on immunosuppressant drugs.
Patients with pre-existing pneumonia, aspiration pneumonitis, ARDS, pulmonary edema and CHF.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To study the incidence of VAP and its microbiological profiling from the endotracheal isolate of mechanically ventilated ICU patients.
 
24 hours , 72 to 96 hours , after 96 hours twice weekly sampling
 
 
Secondary Outcome  
Outcome  TimePoints 
1.To find out the antibiotic susceptibility and sensitivity patterns of the microorganisms isolated and identified in our study.

2.To determine different risk factors in critically ill ICU patients who are on mechanical ventilator support with respect to VAP (Ventilator Associated Pneumonia).

3.To determine, difference between microbiological profile and sensitivity pattern between early and late onset Ventilator Associated Pneumonias.
 
24 hours , 72 to 96 hours , after 96 hours twice weekly sampling
 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Type of Study: Prospective Observational Study.

Objective: To determine the incidence, clinical and microbiological profile, and antibiotic sensitivity patterns of ventilator-associated pneumonia (VAP) in ICU patients.


Background

VAP is the most common hospital acquired infection in ICU settings.

In India, gram-negative resistant organisms are increasingly responsible for VAP.

Despite growing antimicrobial resistance, VAP epidemiology in India remains underreported.


Aims and Objectives

1. Assess VAP incidence in mechanically ventilated ICU patients.


2. Analyze clinical presentation, microbiological findings, and antibiotic sensitivity.


3. Evaluate clinical response and ICU course.


Methodology

Study Setting: Three ICUs in Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGI): Main Post Op ICU, Apex Trauma Centre ICU, PMSSY ICU.

Sample: Minimum of 100 adult ICU patients intubated for more than 48 hours.

Exclusions: Patients from outside SGPGI, immunocompromised, or with pre-existing lung conditions (pneumonia, ARDS, CHF).

ETT Culture Timeline: Within 24 hours of intubation.

Between 72–96 hours.

Biweekly thereafter ( after 96 hours).

 
Close